Cogent Biosciences Participates in Citi Biopharma Back to School Conference

Cogent Biosciences, a biotechnology company, announced its participation in a fireside chat at the Citi Biopharma Back to School Conference on September 3, 2025. The company also announced the grants of "inducement" equity awards to two new employees under its 2020 Inducement Plan with a grant date of August 25, 2025. A live webcast will be available on Cogent's website, and a replay will be archived for up to 30 days.

Cogent Biosciences, a biotechnology company focused on developing precision therapies for genetically defined diseases, announced its participation in the Citi Biopharma Back to School Conference on September 3, 2025. The event, scheduled to take place at 9:00 a.m. ET, will feature a live webcast available on the company's investor relations website. A replay of the webcast will be accessible for 30 days following the event.

Additionally, Cogent Biosciences granted "inducement" equity awards to two new employees under its 2020 Inducement Plan, with a grant date of August 25, 2025. The awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4) and consist of nonqualified options to purchase 54,500 shares of common stock. Each option has a 10-year term, an exercise price equal to the closing price of Cogent's common stock on the grant date, and a four-year vesting schedule with 25% vesting after one year and the remainder vesting in equal monthly installments over the subsequent 36 months, provided the employees remain employed through each vesting date [1].

Cogent Biosciences is based in Waltham, MA and Boulder, CO, and its most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation, among others. The company is also conducting a Phase 1 study of its novel internally discovered FGFR2/3 inhibitor and developing a portfolio of novel targeted therapies for conditions such as systemic mastocytosis and gastrointestinal stromal tumors (GIST) [2].

For more information, visit Cogent Biosciences' website at www.cogentbio.com.

References:
[1] https://www.stocktitan.net/news/COGT/cogent-biosciences-announces-participation-in-the-citi-biopharma-e7erx9ck960t.html
[2] https://www.stocktitan.net/news/COGT/